(Q29614538)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17396134

30 April 2017

1 reference

1 reference

1

Folkman J

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17396134

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17396134

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

April 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17396134

Nature Reviews Drug Discovery

30 April 2017

published in

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17396134

30 April 2017

volume

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17396134

30 April 2017

issue

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17396134

30 April 2017

page(s)

273-86

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17396134

Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis

30 April 2017

cites work

1 reference

Angiogenesis in Psoriasis: Therapeutic Implications

31 March 2020

1 reference

Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis

31 March 2020

1 reference

Interferon alpha therapy of haemangiomas in newborns and infants

31 March 2020

1 reference

Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats

31 March 2020

1 reference

Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

31 March 2020

1 reference

Angiogenesis in atherosclerosis: gathering evidence beyond speculation

31 March 2020

1 reference

Human vascular endothelial cells in culture. Growth and DNA synthesis

31 March 2020

1 reference

Polymers for the sustained release of proteins and other macromolecules

31 March 2020

1 reference

Tumor Growth and Neovascularization: An Experimental Model Using the Rabbit Cornea 2

31 March 2020

1 reference

Tumor-induced angiogenesis: Lack of inhibition by irradiation

31 March 2020

1 reference

Protamine is an inhibitor of angiogenesis

31 March 2020

1 reference

A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment

31 March 2020

1 reference

Transplacental carcinogenesis by stilbestrol

31 March 2020

1 reference

Tumstatin, an endothelial cell-specific inhibitor of protein synthesis

31 March 2020

1 reference

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

31 March 2020

1 reference

Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo

31 March 2020

1 reference

Endogenous angiogenesis inhibitors

31 March 2020

1 reference

Endogenous inhibitors of angiogenesis.

31 March 2020

1 reference

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

31 March 2020

1 reference

Endostatin's antiangiogenic signaling network

31 March 2020

1 reference

The sulfated polysaccharide-peptidoglycan complex potently inhibits embryonic angiogenesis and tumor growth in the presence of cortisone acetate

31 March 2020

1 reference

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

31 March 2020

1 reference

Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells.

31 March 2020

1 reference

Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins

31 March 2020

1 reference

Recent advances in the treatment of Multiple Myeloma

31 March 2020

1 reference

Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic

31 March 2020

1 reference

Intravitreal avastin: the low cost alternative to lucentis?

31 March 2020

1 reference

Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration

31 March 2020

1 reference

Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid

31 March 2020

1 reference

Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey

31 March 2020

1 reference

Treatment of neovascular age-related macular degeneration with Ranibizumab/Lucentis

31 March 2020

1 reference

Ranibizumab: treatment in patients with neovascular age-related macular degeneration

31 March 2020

1 reference

Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.

31 March 2020

1 reference

Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration

31 March 2020

1 reference

Re: Correlational of oral tongue cancer inversion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression, by Kim S-H, Cho NH, Kim K, et al

31 March 2020

1 reference

Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature

31 March 2020

1 reference

'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples

31 March 2020

1 reference

Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases

31 March 2020

1 reference

Involvement of platelets in tumour angiogenesis?

31 March 2020

1 reference

Urinary matrix metalloproteinases and their endogenous inhibitors predict hepatic regeneration after murine partial hepatectomy

31 March 2020

1 reference

Adipose tissue mass can be regulated through the vasculature

31 March 2020

1 reference

Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.

31 March 2020

1 reference

A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis

31 March 2020

1 reference

Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study

31 March 2020

1 reference

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

31 March 2020

1 reference

Developmental biology. The unexpected brains behind blood vessel growth.

31 March 2020

1 reference

Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin

31 March 2020

1 reference

VEGF is required for the maintenance of dorsal root ganglia blood vessels but not neurons during development

31 March 2020

1 reference

A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype

31 March 2020

1 reference

Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis

31 March 2020

1 reference

A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.

31 March 2020

1 reference

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

31 March 2020

1 reference

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

31 March 2020

1 reference

Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium

31 March 2020

1 reference

Evidence by molecular profiling for a placental origin of infantile hemangioma

31 March 2020

1 reference

Reversal of obesity by targeted ablation of adipose tissue

31 March 2020

1 reference

Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence

31 March 2020

1 reference

Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover

31 March 2020

1 reference

The role of VEGF in normal and neoplastic hematopoiesis

31 March 2020

1 reference

Flipping the oncogene switch: illumination of tumor maintenance and regression

31 March 2020

1 reference

Reversible tumorigenesis by MYC in hematopoietic lineages

31 March 2020

1 reference

Transient excess of MYC activity can elicit genomic instability and tumorigenesis

31 March 2020

1 reference

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

31 March 2020

1 reference

Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis

31 March 2020

1 reference

Is oncogene addiction angiogenesis-dependent?

31 March 2020

1 reference

Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy

31 March 2020

1 reference

Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options

31 March 2020

1 reference

Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs).

31 March 2020

1 reference

Mechanisms of resistance to imatinib in CML patients: a paradigm for the advantages and pitfalls of molecularly targeted therapy

31 March 2020

1 reference

Oncogenes and angiogenesis: signaling three-dimensional tumor growth

31 March 2020

1 reference

Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis

31 March 2020

1 reference

High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours

31 March 2020

1 reference

Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells

31 March 2020

1 reference

A high risk of occurrence of sporadic breast cancer in individuals with the 104NN polymorphism of the COL18A1 gene

31 March 2020

1 reference

Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors

31 March 2020

1 reference

Racial differences in the cause-specific prevalence of blindness in east Baltimore

31 March 2020

1 reference

Genetic heterogeneity of angiogenesis in mice.

31 March 2020

1 reference

Genetic loci that control vascular endothelial growth factor-induced angiogenesis

31 March 2020

1 reference

Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice

31 March 2020

1 reference

Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis.

31 March 2020

1 reference

ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage

31 March 2020

1 reference

Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin

31 March 2020

1 reference

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

31 March 2020

1 reference

EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms

31 March 2020

1 reference

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid

31 March 2020

1 reference

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

31 March 2020

1 reference

Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients

31 March 2020

1 reference

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

31 March 2020

1 reference

Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors

31 March 2020

1 reference

Tissue factor and angiogenesis in cancer

31 March 2020

1 reference

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

31 March 2020

1 reference

Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve

31 March 2020

1 reference

Endostatin therapy reveals a U-shaped curve for antitumor activity

31 March 2020

1 reference

PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

31 March 2020

1 reference

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer

31 March 2020

1 reference

Cancer therapy. Setbacks for endostatin

31 March 2020

1 reference

Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action

31 March 2020

1 reference

Tumor-associated endothelial cells with cytogenetic abnormalities.

31 March 2020

1 reference

Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis

31 March 2020

1 reference

Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a.

31 March 2020

1 reference

Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases

31 March 2020

1 reference

Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws

31 March 2020

1 reference

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

31 March 2020

1 reference

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

31 March 2020

1 reference

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

31 March 2020

1 reference

A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer

31 March 2020

1 reference

Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo

31 March 2020

1 reference

Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance.

31 March 2020

1 reference

Restoration of thrombospondin 1 expression in tumor cells harbouring mutant ras oncogene by treatment with low doses of doxycycline.

31 March 2020

1 reference

Angiogenesis in life, disease and medicine

31 March 2020

1 reference

Angiogenesis. A boost for tumor starvation

31 March 2020

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17396134

31 March 2020

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1043012915

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17396134

PubMed publication ID

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017